The central role of the gut in intensive care
暂无分享,去创建一个
[1] D. Scherbak,et al. PROBIOTIC ADMINISTRATION IS ASSOCIATED WITH INCREASED MORTALITY IN ICU PATIENTS WITH CENTRAL VENOUS CATHETERS , 2022, Chest.
[2] G. Pesole,et al. Farnesoid X receptor activation by the novel agonist TC-100 (3α, 7α, 11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid) preserves the intestinal barrier integrity and promotes intestinal microbial reshaping in a mouse model of obstructed bile acid flow. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[3] F. McCullough,et al. The safety and efficacy of probiotic supplementation for critically ill adult patients: a systematic review and meta-analysis , 2022, Nutrition reviews.
[4] Longhui Li,et al. The Significance of NLRP Inflammasome in Neuropsychiatric Disorders , 2022, Brain sciences.
[5] A. Moschetta,et al. Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code” , 2022, Nutrients.
[6] J. Chen,et al. Probiotic Supplementation Prevents the Development of Ventilator-Associated Pneumonia for Mechanically Ventilated ICU Patients: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials , 2022, Frontiers in Nutrition.
[7] Z. Deng,et al. Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial , 2022, Frontiers in Cellular and Infection Microbiology.
[8] A. C. Manetti,et al. Traumatic Brain Injury and Gut Brain Axis: The Disruption of an Alliance. , 2022, Reviews on recent clinical trials.
[9] Chih-Cheng Lai,et al. Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials , 2022, Expert review of anti-infective therapy.
[10] F. Centrone,et al. COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles , 2022, Infectious disease reports.
[11] Chunbo Chen,et al. Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice , 2022, mSystems.
[12] V. Giridharan,et al. A crosstalk between gut and brain in sepsis-induced cognitive decline , 2022, Journal of neuroinflammation.
[13] T. Szakmany,et al. Probiotics for the Prevention of Ventilator-Associated Pneumonia: An Updated Systematic Review and Meta-Analysis of Randomised Controlled Trials , 2022, Nutrients.
[14] M. Del Fabbro,et al. Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Review of the Literature , 2022, International journal of molecular sciences.
[15] C. Tong,et al. The pathogens of secondary infection in septic patients share a similar genotype to those that predominate in the gut , 2022, Critical Care.
[16] J. Wortman,et al. SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. , 2022, The New England journal of medicine.
[17] J. Timsit,et al. The role of the microbiota in the management of intensive care patients , 2022, Annals of Intensive Care.
[18] S. Choi,et al. Role of Probiotics in the Management of COVID-19: A Computational Perspective , 2022, Nutrients.
[19] F. Duška,et al. Multi-donor Fecal Microbial Transplantation for Critically Ill Patients: Rationale and Standard Operating Procedure , 2021, Future Pharmacology.
[20] Myung-Gyu Kim,et al. Probiotics partially attenuate the severity of acute kidney injury through an immunomodulatory effect , 2021, Kidney research and clinical practice.
[21] Juliana Gondim de Albuquerque,et al. Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19? , 2021, Nutrition research reviews.
[22] A. Chorti,et al. A FOUR PROBIOTIC PREPARATION FOR VENTILATOR-ASSOCIATED PNEUMONIA IN MULTI-TRAUMA PATIENTS: RESULTS OF A RANDOMIZED CLINICAL TRIAL. , 2021, International journal of antimicrobial agents.
[23] Paul W. Dul,et al. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial. , 2021, JAMA.
[24] Ryan M. Thomas,et al. Bacteria and Sepsis: Microbiome to the Rescue? , 2021, Journal of clinical medicine.
[25] S. Halvorsen,et al. Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial , 2021, EBioMedicine.
[26] Qifang Zhang,et al. Activation of NLRP3 Inflammasome and Onset of Alzheimer’s Disease , 2021, Frontiers in Immunology.
[27] M. Connelly,et al. Circulating trimethylamine‐N‐oxide is associated with all‐cause mortality in subjects with nonalcoholic fatty liver disease , 2021, Liver international : official journal of the International Association for the Study of the Liver.
[28] Mahavir Singh,et al. Rebuilding Microbiome for Mitigating Traumatic Brain Injury: Importance of Restructuring the Gut-Microbiome-Brain Axis , 2021, Molecular Neurobiology.
[29] Xiaochuan Sun,et al. Fecal Microbiota Transplantation Is a Promising Method to Restore Gut Microbiota Dysbiosis and Relieve Neurological Deficits after Traumatic Brain Injury , 2021, Oxidative medicine and cellular longevity.
[30] OUP accepted manuscript , 2021, Journal of Antimicrobial Chemotherapy.
[31] F. Ronchi,et al. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology , 2020, Frontiers in Immunology.
[32] J. P. de Rivero Vaccari,et al. Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets , 2020, Journal of neuroinflammation.
[33] J. Pu,et al. NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin , 2020, Neuroscience.
[34] Jennifer R. Defazio,et al. The use of fecal microbiota transplant in sepsis. , 2020, Translational research : the journal of laboratory and clinical medicine.
[35] Annika Lundqvist,et al. The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study. , 2020, Cell metabolism.
[36] W. Jia,et al. Age-related compositional changes and correlations of gut microbiome, serum metabolome, and immune factor in rats , 2020, GeroScience.
[37] B. Shakhsheer,et al. Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunity , 2020, Nature Communications.
[38] Huiping Xu,et al. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[39] Y. Liu,et al. High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients , 2019, BMC Nephrology.
[40] Kok Jf,et al. Ribaxamase, an orally administered β-lactamase, protects the gut microbiome in patients treated with ceftriaxone , 2020 .
[41] R. Amathieu,et al. Management of liver failure in General Intensive Care Unit. , 2020, Anaesthesia, critical care & pain medicine.
[42] P. Anderson,et al. The Importance of the Microbiome in Critically Ill Patients: Role of Nutrition , 2019, Nutrients.
[43] N. Shime,et al. Unique patterns of lower respiratory tract microbiota are associated with inflammation and hospital mortality in acute respiratory distress syndrome , 2019, Respiratory Research.
[44] Miriam H. Huntley,et al. Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. , 2019, The New England journal of medicine.
[45] R. Bataller,et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease , 2019, Nature.
[46] A. Gasbarrini,et al. Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition , 2019, Nutrients.
[47] Ruifu Yang,et al. Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae. , 2019, Cell metabolism.
[48] W. Ling,et al. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease. , 2019, Molecular nutrition & food research.
[49] C. Mackay,et al. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] M. Derrien,et al. The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response , 2019, Scientific Reports.
[51] C. Coopersmith,et al. The microbiome and nutrition in critical illness , 2019, Current opinion in critical care.
[52] F. Ding,et al. Serum indoxyl sulfate is associated with mortality in hospital-acquired acute kidney injury: a prospective cohort study , 2019, BMC Nephrology.
[53] A. Parian,et al. Fecal Microbiota Transplantation for the Critically Ill Patient , 2018, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[54] C. Pichard,et al. ESPEN guideline on clinical nutrition in the intensive care unit. , 2019, Clinical nutrition.
[55] E. Kuijper,et al. Clinical Application and Potential of Fecal Microbiota Transplantation. , 2019, Annual review of medicine.
[56] P. Stenvinkel,et al. Effects of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Levels in Hemodialysis Patients: a Pilot Study , 2019, Probiotics and Antimicrobial Proteins.
[57] C. B. de La Serre,et al. Microbiota modulation by eating patterns and diet composition: impact on food intake. , 2018, American journal of physiology. Regulatory, integrative and comparative physiology.
[58] M. Hattori,et al. Gut microbiota-derived D-serine protects against acute kidney injury. , 2018, JCI insight.
[59] A. Gasbarrini,et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions , 2018, Alimentary pharmacology & therapeutics.
[60] T. Spector,et al. Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.
[61] F. Hugenholtz,et al. The emerging role of the microbiota in the ICU , 2018, Critical Care.
[62] D. Jain,et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans , 2018, Science.
[63] N. Ampel. Blunting the Effects of Antibiotics on the Intestinal Microbiome , 2018 .
[64] D. Raoult,et al. Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[65] J. Kaczmarek,et al. Time of day and eating behaviors are associated with the composition and function of the human gastrointestinal microbiota. , 2017, The American journal of clinical nutrition.
[66] Huiping Xu,et al. Fecal Microbiota Transplant Decreases Mortality in Patients With Refractory Severe and Severe Complicated Clostridium difficile Infection Not Eligible for Colectomy: 2017 Fellows-in-Training Award (Colon Category): 100 , 2017 .
[67] Robert D. Stedtfeld,et al. Modulatory Influence of Segmented Filamentous Bacteria on Transcriptomic Response of Gnotobiotic Mice Exposed to TCDD , 2017, Front. Microbiol..
[68] G. Cresci,et al. Prophylactic tributyrin treatment mitigates chronic‐binge ethanol‐induced intestinal barrier and liver injury , 2017, Journal of gastroenterology and hepatology.
[69] I. Komuro,et al. Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure , 2017, Korean circulation journal.
[70] J. de Gunzburg,et al. Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis , 2017, Antimicrobial Agents and Chemotherapy.
[71] N. Bhala,et al. Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection , 2017, Alimentary pharmacology & therapeutics.
[72] M. Bertrand,et al. RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis. , 2017, Journal of hepatology.
[73] H. Tilg,et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease , 2017, Gut.
[74] A. El-Osta,et al. High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice , 2017, Circulation.
[75] R. Kelishadi,et al. Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents , 2017, Journal of pediatric gastroenterology and nutrition.
[76] H. Tilg,et al. European consensus conference on faecal microbiota transplantation in clinical practice , 2017, Gut.
[77] Huiping Xu,et al. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach , 2016, Gut microbes.
[78] M. Fischbach,et al. Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota. , 2016, Cell host & microbe.
[79] P. Popovich,et al. Gut dysbiosis impairs recovery after spinal cord injury , 2016, The Journal of experimental medicine.
[80] T. van der Poll,et al. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study , 2016, Intensive Care Medicine.
[81] Dongfeng Chen,et al. Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis , 2016, Critical Care.
[82] S. Tzipori,et al. Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection. , 2016, Anaerobe.
[83] Rob Knight,et al. Extreme Dysbiosis of the Microbiome in Critical Illness , 2016, mSphere.
[84] A. Waisman,et al. Gut Microbiota Promote Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction , 2016, Journal of the American Heart Association.
[85] P. Wischmeyer,et al. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis , 2016, Critical Care.
[86] A. Levin,et al. Neonatal gut microbiota associates with childhood multi–sensitized atopy and T–cell differentiation , 2016, Nature Medicine.
[87] S. Roos,et al. Lactobacillus reuteri increases mucus thickness and ameliorates dextran sulphate sodium‐induced colitis in mice , 2016, Acta physiologica.
[88] R. Knight,et al. Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness , 2016, Current opinion in critical care.
[89] A. Xu,et al. Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice , 2016, Circulation.
[90] Jennifer R. Defazio,et al. The Shift of an Intestinal “Microbiome” to a “Pathobiome” Governs the Course and Outcome of Sepsis Following Surgical Injury , 2016, Shock.
[91] A. Day,et al. Enteral versus parenteral nutrition in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials , 2016, Critical Care.
[92] O. Mathieu,et al. Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[93] R. Aquilani,et al. Pathogenic Gut Flora in Patients With Chronic Heart Failure. , 2016, JACC. Heart failure.
[94] P. Stenvinkel,et al. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease , 2016, PloS one.
[95] Hong-wei Zhang,et al. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults , 2016, Scientific Reports.
[96] R. Milo,et al. Revised Estimates for the Number of Human and Bacteria Cells in the Body , 2016, bioRxiv.
[97] B. Shenderov,et al. Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota , 2016, Microbial ecology in health and disease.
[98] S. Hazen,et al. Choline Diet and Its Gut Microbe–Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload–Induced Heart Failure , 2016, Circulation. Heart failure.
[99] M. Wong,et al. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition , 2015, Molecular Psychiatry.
[100] R. Dickson. The microbiome and critical illness. , 2016, The Lancet. Respiratory medicine.
[101] L. Eckmann,et al. Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury. , 2015, Alcoholism, clinical and experimental research.
[102] T. van der Poll,et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia , 2015, Gut.
[103] Xinying Wang,et al. Partial Enteral Nutrition Preserves Elements of Gut Barrier Function, Including Innate Immunity, Intestinal Alkaline Phosphatase (IAP) Level, and Intestinal Microbiota in Mice , 2015, Nutrients.
[104] H. Sokol,et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease , 2015, Gut.
[105] Rustem F. Ismagilov,et al. Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis , 2015, Cell.
[106] M. Silver,et al. Impact of the Dash Diet on Endothelial Function, Exercise Capacity, and Quality of Life in Patients with Heart Failure , 2015, Proceedings.
[107] Jun Gu,et al. Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy. , 2015, Journal of the American Society of Nephrology : JASN.
[108] Seppo Salminen,et al. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial , 2015, Pediatric Research.
[109] E. Mesquita,et al. Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial. , 2015, International journal of cardiology.
[110] Omry Koren,et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome , 2015, Nature.
[111] S. Hazen,et al. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. , 2015, Annual review of medicine.
[112] Vinícius Andrade-Oliveira,et al. Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion. , 2015, Journal of the American Society of Nephrology : JASN.
[113] Young Don Kim,et al. Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study , 2014, European journal of gastroenterology & hepatology.
[114] K. Nelson,et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. , 2015, Gastroenterology.
[115] Lai Guan Ng,et al. The gut microbiota influences blood-brain barrier permeability in mice , 2014, Science Translational Medicine.
[116] Therapeutic Modulation and Reestablishment of the Intestinal Microbiota With Fecal Microbiota Transplantation Resolves Sepsis and Diarrhea in a Patient , 2014, The American Journal of Gastroenterology.
[117] B. Shakhsheer,et al. Membership and Behavior of Ultra-Low-Diversity Pathogen Communities Present in the Gut of Humans during Prolonged Critical Illness , 2014, mBio.
[118] S. Anker,et al. Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. , 2014, Journal of the American College of Cardiology.
[119] H. Rabb,et al. Intestinal Microbiota-Kidney Cross Talk in Acute Kidney Injury and Chronic Kidney Disease , 2014, Nephron Clinical Practice.
[120] J. Chastre,et al. Antibiotic stewardship in the intensive care unit , 2014, Critical Care.
[121] Glenn R. Gibson,et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .
[122] W. D. de Vos,et al. The first 1000 cultured species of the human gastrointestinal microbiota , 2014, FEMS microbiology reviews.
[123] G. Gloor,et al. Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat , 2014, Circulation. Heart failure.
[124] G. Andersen,et al. Expansion of Urease- and Uricase-Containing, Indole- and p-Cresol-Forming and Contraction of Short-Chain Fatty Acid-Producing Intestinal Microbiota in ESRD , 2014, American Journal of Nephrology.
[125] T. Junt,et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis , 2014, Nature Medicine.
[126] C. Buffie,et al. Microbiota-mediated colonization resistance against intestinal pathogens , 2013, Nature Reviews Immunology.
[127] S. Zeisel,et al. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[128] P. Wischmeyer,et al. Probiotic Administration Reduces Mortality and Improves Intestinal Epithelial Homeostasis in Experimental Sepsis , 2013, Anesthesiology.
[129] G. Xie,et al. Chronic ethanol consumption alters mammalian gastrointestinal content metabolites. , 2013, Journal of proteome research.
[130] J. Gordon,et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation , 2013, Proceedings of the National Academy of Sciences.
[131] Rob Knight,et al. Defining the human microbiome. , 2012, Nutrition reviews.
[132] K. Brown,et al. Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease , 2012, Nutrients.
[133] J. Kabeerdoss,et al. Effect of yoghurt containing Bifidobacterium lactis Bb12® on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers , 2011, Nutrition journal.
[134] F. Bushman,et al. Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.
[135] M. Kollef,et al. Antibiotic stewardship in the intensive care unit. , 2011, Seminars in respiratory and critical care medicine.
[136] M. Hayakawa,et al. Dramatic Changes of the Gut Flora Immediately After Severe and Sudden Insults , 2011, Digestive Diseases and Sciences.
[137] Brian J. Bennett,et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.
[138] A. Fodor,et al. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. , 2011, Gastroenterology.
[139] J. Tieppo,et al. Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis. , 2011, Arquivos de gastroenterologia.
[140] Z. Tonar,et al. Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. , 2010, Journal of atherosclerosis and thrombosis.
[141] A. Wolk,et al. Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years. , 2009, The American journal of cardiology.
[142] R. Knight,et al. The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice , 2009, Science Translational Medicine.
[143] R. Xavier,et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.
[144] I. Baguley,et al. Dysautonomia after Severe Traumatic Brain Injury: Evidence of Persisting Overresponsiveness to Afferent Stimuli , 2009, American journal of physical medicine & rehabilitation.
[145] Naomi Jones,et al. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study , 2009, Intensive Care Medicine.
[146] A. Wolk,et al. Consistency with the DASH diet and incidence of heart failure. , 2009, Archives of internal medicine.
[147] B. Roth,et al. The expanded biology of serotonin. , 2009, Annual review of medicine.
[148] K. Zimmermann,et al. Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans , 2009, Mucosal Immunology.
[149] J. Doré,et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.
[150] K. Fellermann,et al. Probiotic lactobacilli and VSL#3 induce enterocyte β‐defensin 2 , 2008, Clinical and experimental immunology.
[151] E. Benarroch,et al. Enteric nervous system , 2007, Neurology.
[152] P. Poole‐Wilson,et al. Altered intestinal function in patients with chronic heart failure. , 2007, Journal of the American College of Cardiology.
[153] C. Coopersmith,et al. INTESTINAL CROSSTALK: A NEW PARADIGM FOR UNDERSTANDING THE GUT AS THE "MOTOR" OF CRITICAL ILLNESS , 2007, Shock.
[154] T. Fiore,et al. Jaundice in critical illness: promoting factors of a concealed reality , 2006, Intensive Care Medicine.
[155] Y. Chida,et al. Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice , 2004, The Journal of physiology.
[156] Ji-Xin Shi,et al. Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction. , 2004, World journal of gastroenterology.
[157] Jeffrey B. Cheng,et al. Molecular Genetics of 3β-Hydroxy-Δ5-C27-Steroid Oxidoreductase Deficiency in 16 Patients with Loss of Bile Acid Synthesis and Liver Disease , 2003 .
[158] D. Sachar,et al. Pulmonary Manifestations of Inflammatory Bowel Disease , 2003, Inflammatory bowel diseases.
[159] P. Koski,et al. Enzymic degradation of a beta-lactam antibiotic, ampicillin, in the gut: a novel treatment modality. , 2003, The Journal of antimicrobial chemotherapy.
[160] Jeffrey B. Cheng,et al. Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease. , 2003, The Journal of clinical endocrinology and metabolism.
[161] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[162] S. Atiş,et al. Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome , 2001, American Journal of Gastroenterology.
[163] D. Cockcroft,et al. Constrictive bronchiolitis and ulcerative colitis. , 1999, Canadian respiratory journal.
[164] A. Wells,et al. Bronchiectasis following colectomy for Crohn’s disease , 1998, Thorax.
[165] D. Russell,et al. Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. , 1996, The Journal of biological chemistry.
[166] D. Jenden,et al. Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation , 1995, Hepatology.
[167] D. Jenden,et al. Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. , 1993, Clinical nutrition.
[168] R. H. Earle,et al. Unexplained bronchopulmonary disease with inflammatory bowel disease. , 1976, Archives of internal medicine.
[169] G. Bertaccini. Tissue 5‐hydroxytryptamine and urinary 5‐hydroxyindoleacetic acid after partial or total removal of the gastro‐intestinal tract in the rat , 1960, The Journal of physiology.
[170] V. Erspamer,et al. Observations on the Release and Turnover Rate of 5‐Hydroxytryptamine in the Gastrointestinal Tract , 1959, The Journal of pharmacy and pharmacology.
[171] A. J. Wood,et al. Action of Enterobacteriaceae on Choline and Related Compounds , 1947 .